The Supreme Court heard arguments on Monday in a case that could determine the fate of Purdue Pharma's bankruptcy plan, which includes a provision protecting the Sackler family from liability for the opioid epidemic. The Biden administration has objected to the plan, arguing that it gives the Sacklers too much protection, and justices expressed skepticism that a bankruptcy court had legal authority to release the Sacklers from potential legal claims. The Supreme Court's decision could have far-reaching implications for the opioid epidemic and the Sackler family, as it will determine whether the Sacklers will be protected from future civil lawsuits.
